We are live on ! Find out more
DA

DCF Advisers Portfolio holdings

AUM $375M
1-Year Est. Return 72.65%
This Fund
S&P 500
This Quarter Est. Return
-1.84%
1 Year Est. Return
+72.65%
3 Year Est. Return
+156.29%
5 Year Est. Return
+218.72%
10 Year Est. Return
–
AUM
$227M
AUM Growth
-$55.7M
Cap. Flow
-$49.7M
Cap. Flow %
-21.93%
Top 10 Hldgs %
50.08%
Holding
105
New
12
Increased
23
Reduced
19
Closed
24

Top Buys

Rank Stock Value
1
IMPL
Impel Pharmaceuticals Inc. Common Stock
IMPL
+$2.18M
2
ARGX icon
argenx
ARGX
+$1.58M
3
ALT icon
Altimmune
ALT
+$1.14M
4
AAPL icon
Apple
AAPL
+$1.1M
5
XNCR icon
Xencor
XNCR
+$1.08M

Top Sells

Rank Stock Value
1
GOOG icon
Alphabet (Google) Class C
GOOG
+$5.93M
2
KIN
Kindred Biosciences, Inc.
KIN
+$3.32M
3
ORCL icon
Oracle
ORCL
+$1.99M
4
GLD icon
SPDR Gold Trust
GLD
+$1.67M
5
AMD icon
Advanced Micro Devices
AMD
+$1.53M

Sector Composition

Rank Sector Weight
1 Healthcare 38.05%
2 Technology 12.14%
3 Communication Services 8.72%
4 Financials 5.36%
5 Consumer Discretionary 4.11%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
TBHC
76
DELISTED
The Brand House Collective
TBHC
$211K 0.09%
11,000
– –
ET icon
77
Energy Transfer Partners
ET
$70.1B
$206K 0.09%
+21,500
New +$206K
MTNB icon
78
Matinas BioPharma
MTNB
$1.88M
$201K 0.09%
3,090
-4,629
-60% -$200K
QTNT
79
DELISTED
Quotient Limited Ordinary Shares
QTNT
$196K 0.09%
2,098
-427
-17% -$53.3K
VLD.WS
80
DELISTED
Velo3D, Inc. Redeemable warrants, each Warrant exercisable for 1/35th of a share of Common Stock at an exercise price of $402.50
VLD.WS
$72K 0.03%
+42,000
New +$64.7K
IMDX
81
Insight Molecular Diagnostics
IMDX
$150M
$43K 0.02%
+607
New +$55.8K
AAPL icon
82
CALL
Apple
AAPL
$4.54T
– –
-9,000
Closed -$1.23M
BMY icon
83
CALL
Bristol-Myers Squibb
BMY
$133B
– –
-25,000
Closed -$1.67M
FDX icon
84
CALL
FedEx
FDX
$72.7B
– –
-1,700
Closed -$507K
GEN icon
85
Gen Digital
GEN
$16.4B
– –
-15,000
Closed -$408K
GLD icon
86
PUT
SPDR Gold Trust
GLD
$131B
– –
-20,000
Closed -$3.31M
GMAB icon
87
Genmab
GMAB
$17.7B
– –
-10,000
Closed -$408K
IBM icon
88
IBM
IBM
$211B
– –
-5,230
Closed -$733K
JNJ icon
89
Johnson & Johnson
JNJ
$618B
– –
-5,000
Closed -$824K
KSS icon
90
Kohl's
KSS
$2.17B
– –
-10,000
Closed -$551K
KWEB icon
91
KraneShares CSI China Internet ETF
KWEB
$5.64B
– –
-7,500
Closed -$523K
LIT icon
92
CALL
Global X Lithium & Battery Tech ETF
LIT
$1.51B
– –
-4,500
Closed -$326K
MAS icon
93
CALL
Masco
MAS
$14.1B
– –
-5,000
Closed -$295K
MU icon
94
PUT
Micron Technology
MU
$930B
– –
-20,000
Closed -$1.7M
PARA
95
CALL
DELISTED
Paramount Global Class B
PARA
– –
-5,000
Closed -$226K
QQQ icon
96
CALL
Invesco QQQ Trust
QQQ
$453B
– –
-12,500
Closed -$4.43M
SGMO
97
DELISTED
SANGAMO THERAPEUTICS INC
SGMO
– –
-13,100
Closed -$157K
TSM icon
98
TSMC
TSM
$2.1T
– –
-2,500
Closed -$300K
TSM icon
99
PUT
TSMC
TSM
$2.1T
– –
-10,000
Closed -$1.2M
XLE icon
100
PUT
State Street Energy Select Sector SPDR ETF
XLE
$39.6B
– –
-9,000
Closed -$242K
1 2 3
4
5

Similar funds

JIC
JRM Investment Counsel Omaha, Nebraska $375M AUM 13.43% 1-Year Est. Return
CIM
CIM Investment Management Pittsburgh, Pennsylvania $375M AUM 32.03% 1-Year Est. Return
AIM
Access Investment Management Atlanta, Georgia $376M AUM 17.2% 1-Year Est. Return
MWM
McMill Wealth Management Norfolk, Nebraska $376M AUM 14.46% 1-Year Est. Return
RCP
RIT Capital Partners London, United Kingdom $374M AUM 25.18% 1-Year Est. Return
HPM
Helix Partners Management New York $374M AUM 136.73% 1-Year Est. Return
CAG
Compass Advisory Group Melville, New York $374M AUM 14.59% 1-Year Est. Return
LWMNY
Landmark Wealth Management (New York) Melville, New York $373M AUM 12.01% 1-Year Est. Return

DCF Advisers's Q3 2021 Portfolio in Review

As of Q3 2021, DCF Advisers held 105 positions worth $227M, down 20% from $282M the previous quarter. Its ten largest holdings account for 50% of the portfolio.

DCF Advisers withdrew a net $49.7M in Q3 2021, closing 24 positions and reducing 19 holdings. Its most notable exit was Kindred Biosciences, Inc., an estimated $3.32M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 38% of assets, up from 29% a quarter earlier, followed by Technology and Communication Services.

Against the trend, DCF Advisers opened a new position in Impel Pharmaceuticals Inc. Common Stock worth $1.83M.

  • DCF Advisers's largest Q3 2021 buy was Impel Pharmaceuticals Inc. Common Stock: 150,000 shares worth $1.83M.
  • DCF Advisers added most to argenx in Q3 2021, an estimated $1.58M increase.
  • DCF Advisers's biggest Q3 2021 reduction was Alphabet (Google) Class C, cutting an estimated $5.93M.
  • DCF Advisers fully exited Kindred Biosciences, Inc. in Q3 2021, selling an estimated $3.32M.
  • DCF Advisers's ten largest holdings make up 50% of its $227M portfolio in Q3 2021.
  • DCF Advisers opened 12 new positions and closed 24 in Q3 2021.
  • DCF Advisers's portfolio value fell 20% quarter-over-quarter to $227M.

Based on DCF Advisers's 13F filing for Q3 2021, filed 15 Nov 2021.